Protagonist Therapeutics, Inc. earnings per share and revenue

PTGX earnings per share for the last quarter are 3.26 USD whereas the estimation was 3.37 USD which accounts for -3.17% surprise. Företagets omsättning för samma period uppgår till 254.95 M USD trots den uppskattade siffran 262.50 M USD. Estimated earnings per share for the next quarter are -0.60 USD, and revenue is expected to reach 56.67 M USD. Also watch annual changes over time to get a bigger picture of PTGX earnings per share and revenue dynamics.